Alpha-1-syntrophin protein is differentially expressed in human cancers

References

• Adams ME, Butler MH, Dwyer TM, Peters MF, Murnane AA, Froehner SC. (1993). Two forms of mouse syntrophin, a 58 kD dystrophin-associated protein, differ in primary structure and tissue distribution. Neuron 11:531–40.
   PubMed Web of Science ®Google Scholar
• Ahn AH, Freener CA, Gussoni E, Yoshida M, Ozawa E, Kunkel LM. (1996). The three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal location, and each bind to dystrophin and its relatives. J Biol Chem 271:2724–30.
   PubMedGoogle Scholar
• Ahn AH, Yoshida M, Anderson MS, Freener CA, Selig S, Hagiwara Y, Ozawa E, Kunkel LM. (1994). Cloning of human basic A1, a distinct 59-kDa dystrophin-associated protein encoded on chromosome 8q23–24. Proc Natl Acad Sci USA 91:4446–50.
   PubMedGoogle Scholar
• Angela H, Yury Y, José C, Christopher O, Elias D, Kazuhiko M, Stephen HG. (2004). The phosphoinositol 3, 4-bisphosphate-binding protein TAPP1 interacts with syntrophins and regulates actin cytoskeletal organization. J Biol Chem 279:53717–24.
   PubMedGoogle Scholar
• Bashir M, Kirmani D, Bhat HF, Baba RA, Hamza R, Naqash S, Wani NA, Andrabi KI, Zargar MA, Khanday FA. (2010). P66shc and its downstream Eps8 and Rac1 proteins are upregulated in esophageal cancers. Cell Commun Signal 8:13.
   PubMedGoogle Scholar
• Campbell KP, Kahl SD. (1989). Association of dystrophin and an integral membrane glycoprotein. Nature 338:259–62.
   PubMed Web of Science ®Google Scholar
• Duncan R, Carpenter B, Main LC, Telfer C, Murray GI. (2008). Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer 98:426–33.
   PubMed Web of Science ®Google Scholar
• Froehner SC. (1984). Peripheral proteins of postsynaptic membranes from Torpedo electric organ identified with monoclonal antibodies. J Cell Biol 99:88–96.
   PubMed Web of Science ®Google Scholar
• Gröne J, Weber B, Staub E, Heinze M, Klaman I, Pilarsky C, Hermann K, Castanos-Velez E, Röpcke S, Mann B. (2006). Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin-1, -8 and -12. Int J Colorectal Dis 22:651–9.
   PubMedGoogle Scholar
• Hoffman EP, Brown RH, Kunkel LM. (1987). Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919–28.
   PubMed Web of Science ®Google Scholar
• Hirotsugu T, Yoshihiro K. (2006). Immunohistochemical analysis of p53 in colorectal cancer regarding clinic-pathological correlation and prognostic significance. J Surg Oncol 58:125–8.
   Google Scholar
• Jackson JG, Yoneda T, Clark GM, Yee D. (2000). Elevated levels of p66shc are found in breast cancer cell lines and primary tumors with high metastatic potential. Clin Can Res 6:1135–9.
   PubMed Web of Science ®Google Scholar
• Kasuno K, Naqvi A, DeRicco J, Yamamori T, Santhanam L, Mattagajasingh I, Yang S, Meyskens FL, Bosserhoff AK, Irani K. (2007). Antagonism of p66shc by melanoma inhibitory activity. Cell Death Differentiation 14:1414–21.
   PubMedGoogle Scholar
• Khanday FA, Santhanam L, Kasuno K, Yamamori T, Naqvi A, DeRicco J, Bugayenko A, Mattagajasingh I, Disanza A, Scita G, Irani K. (2006a). SOS-mediated activation of Rac1 by p66shc. J Cell Biol 172:817–22.
   PubMedGoogle Scholar
• Khanday FA, Yamamori T, Singh IM, Zhang Z, Bugayenko A, Naqvi A, Santhanam L, Nabi N, Kasuno K, Day BW, Irani K. (2006b). Rac1 leads to phosphorylation-dependent increase in stability of the p66shc adaptor protein: role in rac1-induced oxidative stress. Mol Biol Cell 17:122–9.
   PubMedGoogle Scholar
• Kramarcy NR, Vidal A, Froehner SC, Sealock R. (1994). Association of utrophin and multiple dystrophin short forms with the mammalian M(r) 58,000 dystrophin-associated protein (syntrophin). J Biol Chem 269:2870–6.
   PubMedGoogle Scholar
• Ku TKS, Nguyen DC, Karaman M, Gill P, Hacia JG, Crowe DL. (2007). Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer. Mol Cancer Res 5:351–62.
   PubMedGoogle Scholar
• Luo S, Chen Y, Lai KO, Arévalo JC, Froehner SC, Adams ME, Chao MV, Ip NY. (2005). α-1-syntrophin regulates ARMS localization at the neuromuscular junction and enhances EphA 4 signaling in an ARMS – dependent manner. J Cell Biol 169:813–24.
   PubMedGoogle Scholar
• Miguel V, Amparo AP, Beatriz G. (2005). Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases. J Biol Chem 280:28936–43.
   PubMedGoogle Scholar
• Montanaro F, Carbonetto S. (2003). Targeting dystroglycan in the brain. Neuron 37:193–6.
   PubMedGoogle Scholar
• Oak SA, Russo K, Petrucci TC, and Jarrett HW. (2001). Mouse 1-syntrophin binding to grb2: further evidence of a role for syntrophin in cell signaling. Biochemistry 40:11270–8.
   PubMedGoogle Scholar
• Oak SA, Zhou YW, Jarrett HW. (2003). Skeletal muscle signaling pathway through the dystrophin glycoprotein complex and Rac1. J Biol Chem 278:39287–95.
   PubMedGoogle Scholar
• Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL. (1993). Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A 90:3710–14.
   PubMed Web of Science ®Google Scholar
• Piluso G, Mirabella M, Ricci E, Belsito A, Abbondanza C,Servidei S, Puca AA,Tonali P, Nigro V. (2000). γ 1- and γ 2-Syntrophins, two novel dystrophin-binding proteins localized in neuronal cells. J Biol Chem 275:15851–60.
   PubMed Web of Science ®Google Scholar
• Sahai E, Marshall CJ. (2002). Rho-GTPases and cancer. Nat Rev Cancer 2:133–42.
   PubMed Web of Science ®Google Scholar
• Scott N, Sagar P, Stewart J, Blair GE, Dixon MF, Quirke P. (1991). p53 in colorectal cancer: clinic-pathological correlation and prognostic significance. Br J Cancer 63:317–19.
   PubMed Web of Science ®Google Scholar
• Sheng M, Sala C. (2001). PDZ domains and the organization of supramolecular complexes. Annu Rev Neurosci 24:1–29.
   PubMed Web of Science ®Google Scholar
• Subauste MC, Nalban P, Adamson ED, Hahn KM. (2005). Vinculin controls PTEN protein level by maintaining the interaction of the adherent junction protein β-catenin with the scaffolding protein MAGI-2. J Biol Chem 280:5676–81.
   PubMed Web of Science ®Google Scholar
• Vazquez F, Grossman SR, Takahashi Y, Rokas MV, Nakamura N, Sellers WR. (2001). Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J Biol Chem 276:48627–30.
   PubMed Web of Science ®Google Scholar
• Wu X, Hepner K, Castelino-Prabhu S, Do D, Kaye MB, Yuan XJ, Wood J, Ross C, Sawyers CL, Whang YE. (2000a). Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc Natl Acad Sci U S A 97:4233–8.
   PubMed Web of Science ®Google Scholar
• Wu Y, Dowbenko D, Spencer S, Laura R, Lee J, Gu Q, Lasky LA. (2000b). Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, a novel membrane-associated guanylate kinase. J Biol Chem 275:21477–85.
   PubMed Web of Science ®Google Scholar
• Yang B, Ibraghimov-Beskrovnaya O, Moomaw CR, Slaughter CA, Campbell KP. (1994). Heterogeneity of the 59-kDa dystrophin associated protein revealed by cDNA cloning and expression. J Biol Chem 269:6040–4.
   PubMedGoogle Scholar
• Yan WZ, Daifeng J, Donald BT, Harry WJ. (2007). Laminin-induced activation of Rac1 and JNKp46 is initiated by Src family kinases and mimics the effects of skeletal muscle contraction. Biochemistry 46:14907–16.
   PubMedGoogle Scholar
• Yan WZ, Oak SA, Susan E, Senogles Harry, WJ. (2004). Laminin-{alpha} 1 globular domains 3 and 4 induce heterotrimeric G protein binding to {alpha}-syntrophin’s PDZ domain and alter intracellular Ca2+ in muscle. Am J Physiol Cell Physiol 288:377–88.
   Google Scholar
• Yukimasa S, Masaki T, Yoshida S, Uchida N, Watanabe S, Usuki H, Yoshiji H, Maeta T, Ebara K, Nakatsu T. (2005). Enhanced expression of p46shc in the nucleus and p52shc in the cytoplasm of human gastric cancer. Int J Oncol 26:905–11.
   PubMedGoogle Scholar